Uterine Cancer Stage 2
Uterine cancer stage 2 involves the main body of the uterus and the cervix.
Stage 2A cancer involves the uterus and only the surface lining of the cervix. Stage 2B cancer involves the uterus and extends into deep layers of the cervix.
A variety of factors ultimately influence a patient’s decision to receive treatment of cancer. The purpose of sustaining treatment of cancer may be to raise symptoms through local control of cancer, increase a patient’s chance of cure, or prolong a patient’s survival. The potential benefits of receiving cancer treatment must be carefully balanced with the potential risks of receiving cancer treatment.
The following is a common overview of the treatment of uterine cancer stage 2. Circumstances unique to your prognostic and situation factors of your cancer may ultimately influence how these common treatment principles are applied.
Most new treatments are progressed in clinical trials. Clinical trials are studies that evaluate the effectiveness of new drugs or treatment plans. The development of more effective cancer treatments requires that innovative and new therapies be evaluated with cancer patients. Participation in a clinical trial may offer to obtain to better treatments and advance the existing knowledge about treatment of this cancer. Clinical trials are available for most stages of cancer. Patients who are interested in participating in a clinical trial should ask the risks and benefits of clinical trials with their physician. To ensure that you are receiving the optimal treatment of your cancer, it is important to stay informed and follow the cancer news in order to learn about new treatments and the results of clinical trials.
Optimal treatment of patients with uterine cancer stage 2 often requires more than one therapeutic approach.
Thus, it is important for patients to be treated at a medical center that can offer multi-modality treatment involving gynecologic oncologists and radiation oncologists.